GSK Collaborates With Angiochem to Develop LSDs Medication

GSK Collaborates With Angiochem to Develop LSDs Medication

As per recent reports, it has been revealed that GSK has entered into a deal with Angiochem in which both the organizations will be working together to develop treatments for Lysosomal Storage Diseases (LSDs). Company officials are of the view that both the organizations are master in their fields, which will help them discover treatment for the disease.

If the pair will be able to develop the medicine then they will be get more than $300 million. Industry experts said that Angiochem will use its rich knowledge of creating novel therapeutic treatments, while GSK will apply its commercialization capability to create medicines for the rare disease.

Drugs are available to treat the problem, but they are not able to restore enzyme function in the Central Nervous System (CNS), which is necessary to derive best results of the medicine. The main aim of Angiochem will be to prepare a drug, which penetrates in the CNS and brings a decline in the symptoms of LSDs.

Lysosomal storage diseases is quite a rare disease, which affects one in 1, 00,000 people. It generally affects children who mostly die at young age or after a few months of the detection of the disease. LSD is not a single disease, but a group of diseases such as Tay Sachs Disease, Fabry Disease, Gaucher's Disease, Pompe Disease and Hunter syndrome.

"”Our collaboration with GSK reflects our belief in the need to effectively address neurological symptoms of lysosomal storage diseases. We are pleased to collaborate with GSK, a committed leader in this rare disease area”, said Jean-Paul Castaigne, who is the President and CEO of Angiochem. Jean further affirmed that the development of the drug will increase their resources as well in the field of EPiC-enzymes.


FrenchTribune Specials

Nuclear fusion reactor could be operation in 10 years: Lockheed Martin

Lockheed Martin, an American global aerospace, defense, security and advanced technology company has built a compact nuclear fusion reactor which is clean, safe and completely sustainable.

In view of the fact that nuclear fusion is such a powerful way to generate energy, it could eventually replace all other forms of energy production...

Most Popular

Europeans remained lactose intolerant well after adopting cheese-making: study

Ancient Europeans remained intolerant to lactose nearly...

Christiana Figuere surges for unity in climate talks

Christiana Figueres, the head of UN'S climate change...

Scottish mothers suffering depression lack help

According to a new report, pregnant and new mothers...

Bonus for avoiding whales for ships

Cargo ships in the US are being paid a bonus for...

Poll

Can Greece Come out of Economic Problems: